Cohen Capital Management Inc. increased its holdings in Elanco Animal Health Incorporated (NYSE: ELAN) during the third quarter by 53.2%, as indicated by the most recent SEC filing that the company submitted. After completing these transactions, the institutional investor now holds 233,706 shares of the company’s stock within their investment portfolio. These transactions occurred during the time above period. Cohen Capital Management Inc. disclosed to the Securities and Exchange Commission (SEC) in its most recent report that the value of its holdings in Elanco Animal Health was $2,900,000.
Recently, institutional investors such as hedge funds and other types of funds have been very active in the market, purchasing and selling shares of a particular company. The total value of Venture Visionary Partners LLC’s holdings increased due to an additional investment of approximately $45,000 in Elanco Animal Health during the second quarter. Fifth Third Bancorp brought its total ownership of Elanco Animal Health up to 100 percent after acquiring an additional 139.6 percent of the company during the second quarter. Following the acquisition of an additional 1,396 shares of the company during the most recent quarter, Fifth Third Bancorp is now the owner of a total of 2,396 shares in the firm, which has resulted in a total value of $47,000 for the company. CKW Financial Group increased the amount of Elanco Animal Health stock owned by 60.0% during the year’s second quarter. Following the purchase of an additional 900 shares during the most recent quarter, the CKW Financial Group now owns 2,400 shares. These shares have a total value of $49,000, thanks to the fact that they were acquired. Eagle Bay Advisors LLC increased the amount of Elanco Animal Health stock owned by 4,040.0% during the second quarter. Eagle Bay Advisors LLC increased its company stock holdings during the most recent quarter by 2,626 shares, bringing the total number of shares bought to 2,691, with a value of $53,000. This brought the total number of shares acquired during the period to 2,691.
Last but not least, Ellevest Inc. increased the percentage of Elanco Animal Health stock owned by 20,170.8% during the third quarter. This was the company’s third consecutive quarterly increase in this metric. After purchasing an additional 4,841 shares of the company’s stock over the preceding three months, Ellevest Inc. now has a total of 4,865 shares of the company’s stock, which are currently valued at a combined sum of $60,000.
In related news, Elanco Animal Health Director John P. Bilbrey purchased 7,500 shares on Friday, November 11th. This is another recent development concerning Elanco Animal Health. Because of the transaction, the director now possesses 41,722 shares of the company’s stock, with a total value of approximately $552,399.28. The director’s purchase of the shares resulted in an average price of $13.24 per share, which resulted in a total cost of $99,300.00 for the transaction. When you follow this link, you will be taken to the SEC filing that contains more information about the acquisition. Corporate insiders currently hold an equity stake in the company, equivalent to 6.40 percent of the total.
During Thursday’s trading session, the price of a share of ELAN fell by $0.02, bringing the total cost of the security to $12.65. Compared to the volume of 110,877 shares, the average number of shares of the company’s stock that changed hands throughout the day was 7,236.969. The company’s market capitalization is currently $6 billion, while its price-to-earnings ratio is -52.71, its price-to-earnings-to-growth ratio is 6.56, and its beta value is 0.90. The company’s potential to increase its future profits is evaluated using the price-to-earnings-to-growth ratio. The value of the current ratio is 1.96, the value of the quick ratio is 1.12, and the value of the debt-to-equity ratio is 0.82. These values are all related to one another. Over the past year, the price of Elanco Animal Health Incorporated has fluctuated between $11.18 and $29.66, reaching a low of $11.18 and a high of $29.66, respectively. The simple moving average for the last 50 days of the company’s stock price is $12.47, and the simple moving average for the last 200 days is $14.75.
Investors received the most recent information regarding Elanco Animal Health’s (NYSE: ELAN) earnings on November 8th, when the company provided the update. The company’s earnings per share for the quarter came in at $0.20, which was $0.04 more than expected, which was $0.16 per share on average.